Eilam Yeini
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 14
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 3
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Ronit Satchi‐Fainaro (26 shared papers)Galia Tiram (8 shared papers)Ron Kleiner (8 shared papers)Sabina Pozzi (9 shared papers)Helena F. Florindo (6 shared papers)Lena Neufeld (4 shared papers)Daniella Vaskovich‐Koubi (3 shared papers)Yulia Liubomirski (2 shared papers)
- Journals
- Cancer Research (6 papers)Journal of Controlled Release (3 papers)Science Advances (2 papers)Nature Nanotechnology (2 papers)Advanced Therapeutics (2 papers)
- Partner nations
- IsraelUnited StatesPortugal
In The Last Decade
Eilam Yeini
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 107
- Biomaterials 166
- Immunology 246
- Oncology 276
- Infectious Diseases 184
- Biomedical Engineering 413
Countries citing papers authored by Eilam Yeini
This map shows the geographic impact of Eilam Yeini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eilam Yeini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eilam Yeini more than expected).
Fields of papers citing papers by Eilam Yeini
This network shows the impact of papers produced by Eilam Yeini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eilam Yeini. The network helps show where Eilam Yeini may publish in the future.
Co-authors
The 25 scholars most cited alongside Eilam Yeini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 249 | |
| 2 | 2019 | 187 | |
| 3 | 2021 | 129 | |
| 4 | 2022 | 80 | |
| 5 | 2017 | 79 | |
| 6 | 2021 | 56 | |
| 7 | 2020 | 54 | |
| 8 | 2016 | 53 | |
| 9 | 2021 | 34 | |
| 10 | 2022 | 34 | |
| 11 | 2018 | 22 | |
| 12 | 2017 | 20 | |
| 13 | 2017 | 17 | |
| 14 | 2018 | 17 | |
| 15 | 2020 | 13 | |
| 16 | 2018 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2024 | 4 | |
| 19 | 2024 | 2 | |
| 20 | 2021 | 2 |
About Eilam Yeini
Eilam Yeini is a scholar working on Oncology, Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Cell Adhesion Molecules Research (4 papers), Cancer Cells and Metastasis (4 papers), RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), 3D Printing in Biomedical Research (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Biomaterials (166 citations), Immunology (246 citations), Oncology (276 citations), Infectious Diseases (184 citations) and Biomedical Engineering (413 citations). Eilam Yeini has collaborated with scholars based in Israel, United States and Portugal. Frequent co-authors include Ronit Satchi‐Fainaro, Galia Tiram, Ron Kleiner, Sabina Pozzi, Helena F. Florindo, Lena Neufeld, Daniella Vaskovich‐Koubi, Yulia Liubomirski, Bárbara Carreira and Rita C. Acúrcio. Their work appears in journals such as Cancer Research, Journal of Controlled Release, Science Advances, Nature Nanotechnology and Advanced Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.